Thanks to Tom Sullivan’s Policy and Medicine blog for this report on Medscape’s video about why U.S. restrictions on industry support of CME are hindering progress in vital medical fields.
An interesting video and script
from MedScape recently discussed a troubling trend in clinical research regarding gastrointestinal (GI) cancers. According to John L. Marshall, Associate Professor of Medicine at Georgetown University, in Washington, DC, all of the major research in this area over the last 5 years “has been led by Europeans, performed by Europeans, and usually with European patients.”
Read more
NEW YORK – (BUSINESS WIRE) – According to Prevention Magazine’s 13th annual national survey Consumer Reaction to DTC Advertising of Prescription Drugs, consumers are paying attention to the FDA regulated “fair balance” mandate between risk and benefit information on all DTC ads; the majority believe pharmaceutical advertising in magazines and television is presented “both fair and balanced.”
Read more
From Tom Sullivan’s Policy and Medicine blog, July 16, 2010:
As drug companies “prepare for new draconian provisions for reporting on financial relationships with academia,” a recent article in Nature Biotechnology investigated whether such efforts to “increase transparency will prove burdensome to researchers and the industry.”
The inquiry stems from “the latest fallout from Senator Charles Grassley’s (R-IA) camp
Read more
From Peter Pitts’s Drugwonks blog:
Please don’t hold the Mayo
Peter Pitts
One of the more interesting subtexts surrounding King James’ move to Miami is the negative economic impact it will have on the economy of Cleveland specifically and Ohio in general.
A similar subtext (albeit one that has been entirely ignored) is the negative economic impact the State of Michigan will experience following the University of Michigan’s recent announcement that it will ban any industry-sponsored CME.
Read more
From Tom Sullivan:
The ACCME released its 2009 Annual Report data. Here are some of the highlights:
In 2009, accredited providers produced more than 95,000 activities — a 5.8% decrease of activities from 2008, and a 15.9% decrease in activities since 2007. In fact, directly sponsored CME activities decreased over 7% between 2008 and 2009.
Read more
From Policy and Medicine:
The Association of American Medical Colleges (AAMC) issued a press release announcing a new report, which “urges U.S. teaching hospitals to establish policies that manage financial relationships between physicians and industry so that they do not influence patient care.”
The report, entitled “In the Interest of Patients: Recommendations for Physician Financial Relationships and Clinical Decision Making,” is the third and final report by the AAMC on managing financial conflicts of interest. The first 2 association reports focused on conflicts of interest in the research and medical education settings. The final report was carried out by a task force convened by the AAMC in 2009. The task force comprised a 20-member panel, which included senior leadership from the nation’s medical schools and teaching hospitals, and was chaired by Patrick J. Brennan, MD, chief medical officer and senior vice president at the University of Pennsylvania Health System.
Read more on their website
Recent Comments